Genetic Networks Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$10M
Genetic Networks General Information
Description
Developer of a drug asset development platform intended to integrate a genome-wide functional assay of drug activity. The company's platform uses applied modular biology and the identification of the optimal intersection between targets and compounds in specific disease spaces through whole-genome genetic perturbation and analysis, enabling biopharma companies to accelerate the discovery and development of optimal candidate compounds for pre-clinical and clinical testing.
Contact Information
Website
www.geneticnetworks.com(Operating Subsidiary)
Corporate Office
- 351 West 46th Street
- Miami Beach, FL 33140
- United States
Corporate Office
- 351 West 46th Street
- Miami Beach, FL 33140
- United States
Genetic Networks Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 20-Mar-2025 | $10M | Completed | Generating Revenue | ||
| 3. Grant | 17-Jul-2019 | Completed | Startup | |||
| 2. Grant | 01-May-2017 | $325K | $40K | Completed | Startup | |
| 1. Accelerator/Incubator | 01-Jan-2015 | $40K | $40K | Completed | Startup |
Genetic Networks Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Genetic Networks Patents
Genetic Networks Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021262825-A2 | Disrupting lipid synthesis: a novel target for broad-spectrum host-directed anti-virulence therapeutics | Inactive | 23-Jun-2020 | ||
| WO-2021262825-A3 | Disrupting lipid synthesis: a novel target for broad-spectrum host-directed anti-virulence therapeutics | Inactive | 23-Jun-2020 |
Genetic Networks Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Institute for Commercialization of Florida Technology | Not-For-Profit Venture Capital | Minority | ||
| National Center For Advancing Translational Sciences | Government | |||
| National Institutes of Health | Government |
Genetic Networks FAQs
-
When was Genetic Networks founded?
Genetic Networks was founded in 2015.
-
Where is Genetic Networks headquartered?
Genetic Networks is headquartered in Miami Beach, FL.
-
What industry is Genetic Networks in?
Genetic Networks’s primary industry is Discovery Tools (Healthcare).
-
Is Genetic Networks a private or public company?
Genetic Networks is a Private company.
-
What is the current valuation of Genetic Networks?
The current valuation of Genetic Networks is .
-
What is Genetic Networks’s current revenue?
The current revenue for Genetic Networks is .
-
How much funding has Genetic Networks raised over time?
Genetic Networks has raised $40K.
-
Who are Genetic Networks’s investors?
Institute for Commercialization of Florida Technology, National Center For Advancing Translational Sciences, and National Institutes of Health have invested in Genetic Networks.
-
When was Genetic Networks acquired?
Genetic Networks was acquired on 20-Mar-2025.
-
Who acquired Genetic Networks?
Genetic Networks was acquired by Fifty 1 Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
